市場調查報告書
商品編碼
1400702
全球 MRI 市場評估:按場強、按設計、按應用、按最終用戶、按地區、機會、預測(2017-2031 年)Magnetic Resonance Imaging Market Assessment, By Field Strength, By Design, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球MRI市場規模預計到2023年將達到74億美元,2031年將達到115.1億美元,2024-2031年預測期間複合年增長率為5.68%。近年來,在重要因素和顯著技術創新的共同推動下,市場呈現顯著成長。市場擴張的主要因素是新興國家老年人口的增加、慢性病盛行率的增加、新技術的引進、安裝的增加和意識的提高。
電腦科學、數據處理和半導體等各領域的新技術正迅速成為 MRI 技術進步的關鍵。這種整合導致了創新應用程式的創建。由於 HPC 和 MRI 技術進步的協同效應,MRI 現在能夠產生大量的功能和解剖成像數據,成為多種疾病的重要資源。MRI 機器成本高、MRI 技術人員短缺等因素對市場產生負面影響。
該市場呈現顯著成長,主要是由於老年人口的增加和慢性病盛行率的增加。近年來,老年人口大幅增加,越來越多的老年人尋求諮詢和診斷服務。隨著年齡的增長,我們對各種健康問題的敏感度增加,包括心血管疾病、癌症和神經系統疾病等慢性疾病。到 2030 年,世界上六分之一的人將年齡在 60 歲或以上。在此期間,全球60歲及以上人口比例將從2020年的10億增加到14億。到2050年,全球60歲及以上的人口預計將增加一倍,達到21億。此外,預計 2020 年至 2050 年間,80 歲及以上的人口數量將增加兩倍,達到 4.26 億。事實證明,MRI 技術對於這些疾病的早期檢測、準確診斷和監測非常有用。MRI 是醫療專業人員的首選,因為它是非侵入性的並且提供高解析度成像。MRI 有助於檢測動脈瘤、眼/耳疾病、中風、腫瘤、腦損傷和韌帶損傷等疾病。因此,隨著醫療保健提供者和患者認識到技術在改善患者治療結果和支持更有效的醫療保健管理方面的作用,對 MRI 技術的需求正在迅速增加。
MRI 技術的進步正在加速市場創新。高場 MRI 掃描儀、多參數成像和人工智慧影像分析等新發展顯著提高了影像品質和診斷準確性。此外,功能性 MRI (fMRI) 和擴散張量成像 (DTI) 的整合正在開啟理解大腦功能和連接性的新可能性,有助於神經系統疾病的診斷和治療。此外,MRI 機器的小型化和便攜式系統的出現使偏遠和服務不足的地區更容易使用這種診斷工具。
目前,高場強MRI和超高場強MRI技術佔據市場主導地位。這些先進的 MRI 系統提供高影像分辨率,可進行更精確和詳細的診斷。高場MRI(通常在1.5 特斯拉或3 特斯拉下運行)已成為各種臨床應用的標準,而超高場MRI(在4 特斯拉或更高的功率下運行)正在研究和專業臨床環境中獲得關注。 。這些強大的 MRI 系統有助於神經影像學、心血管研究和神經疾病研究,提供以前難以收集的寶貴見解。在高場強下工作的主要優點是提高訊號雜訊比和增強化學位移。高信噪比可用於減少掃描時間或提高空間分辨率,而不會影響診斷品質。
新興國家的核磁共振設備安裝量不斷增加,為醫療基礎設施帶來了重大變化。這一增長可歸因於醫療保健預算增加、中等收入人口不斷增長以及對先進醫學影像在早期診斷和治療中重要作用的認識等因素。此外,這種擴張是由於醫療保健專業人員和公眾對 MRI 在檢測和監測各種醫療狀況方面的好處的認識不斷提高而推動的。MRI 服務的可用性增加了獲得優質醫療照護的機會,從而實現更準確的診斷並改善患者的治療結果。這一趨勢反映了縮小已開發國家和新興國家之間醫療保健差距的積極一步。
本報告研究和分析了全球 MRI 市場,提供市場規模和預測、市場動態、主要參與者的現狀和前景等。
Global magnetic resonance imaging market size was valued at USD 7.4 billion in 2023, expected to reach USD 11.51 billion in 2031, with a CAGR of 5.68% for the forecast period between 2024 and 2031F. The global magnetic resonance imaging market has experienced substantial growth in recent years, driven by a convergence of key factors and fueled by remarkable innovations. Market expansion is primarily attributed to the growing geriatric population, increasing incidence of chronic diseases, introduction of novel technologies, and increasing installation and growing awareness in emerging countries.
Emerging technologies from different fields such as computer science, data processing, and semiconductors have quickly become integral to advancements in MRI technology. This integration has led to the creation of innovative applications. Through the synergies of high-performance computing and advancements in MRI technology, MRI can now generate extensive sets of both functional and anatomical image data, which serves as a vital resource across multiple diseases. Factors such as the high cost of MRI machines and the shortage of MRI technologists are negatively impacting the global magnetic resonance imaging (MRI) market.
The global magnetic resonance imaging market is experiencing substantial growth, largely driven by the growing geriatric population and the rising incidence of chronic diseases. The aging demographic has considerably increased in recent years, with more elderly individuals seeking medical attention and diagnostic services. As individuals age, their susceptibility to various health issues, including chronic diseases such as cardiovascular conditions, cancer, and neurological disorders, increases. By the year 2030, one out of every six individuals worldwide will have reached the age of 60 or older. During this period, the proportion of global population comprising those aged 60 and above will rise from 1 billion in 2020 to 1.4 billion. Looking ahead to 2050, the global population of individuals aged 60 and older is projected to double, reaching 2.1 billion. Furthermore, the number of people aged 80 or older is anticipated to triple between 2020 and 2050, reaching 426 million. MRI technology has proven valuable in the early disease detection, accurate diagnosis, and monitoring of these conditions. It offers non-invasive, high-resolution imaging, making it a preferred choice for healthcare professionals. MRI aids in detecting conditions such as aneurysm, eye/ear disorders, stroke, tumor, brain injuries, and ligament injuries. Consequently, the demand for MRI technologies has surged as healthcare providers and patients recognize technology's role in improving patient outcomes and ensuring more efficient healthcare management.
Advancements in MRI technologies have accelerated innovation in the global magnetic resonance imaging (MRI) market. Novel developments, such as higher-field MRI scanners, multi-parametric imaging, and AI-driven image analysis, have significantly improved image quality and diagnostic accuracy. Furthermore, the integration of functional MRI (fMRI) and diffusion tensor imaging (DTI) has unlocked new possibilities in understanding brain function and connectivity, aiding in the diagnosis and treatment of neurological conditions. Additionally, the miniaturization of MRI machines and the advent of portable systems have made this diagnostic tool more accessible, even in remote or underserved regions.
In September 2023, the FDA granted regulatory approval for IGAR, a robotics system created by Insight Medbotics, making it the first and only robotic platform specifically engineered to operate within the MRI bore. The pioneering technology, IGAR, has the potential for future adaptations to function in various hospital settings. Insight Medbotics has showcased the safety and effectiveness of IGAR through publicly available clinical studies focused on breast biopsy procedures.
At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 Annual Meeting, GE Healthcare introduced its SIGNA PET/MR AIR. During the event, the company presented the incorporation of its state-of-the-art AIR technologies into the SIGNA PET/MR AIR system, aiming to improve diagnostic accuracy, streamline treatment assessment, and enhance the overall comfort of patients.
High field strength MRI and ultra-high field strength MRI technologies are currently dominating the MRI market. These advanced MRI systems offer high image resolution, allowing for more precise and detailed diagnosis. High field MRI, typically operating at 1.5 Tesla or 3 Tesla, has become the standard for various clinical applications, while ultra-high field MRI, operating beyond 4 Tesla or higher, is gaining prominence in research and specialized clinical settings. These powerful MRI systems are instrumental in neuroimaging, cardiovascular studies, and research into neurological disorders, providing invaluable insights that were previously difficult to gather. The primary benefits of operating at high field strengths include an increased signal-to-noise ratio and enhanced chemical shift. High signal-to-noise ratio can be used to either reduce scanning time without compromising diagnostic quality or to enhance spatial resolution.
In February 2023, A group of seven organizations, led by the Donders Institute of Brain, Cognition, and Behavior, has been awarded EUR 19 million roadmap grant from the Dutch Research Council. This funding will be dedicated to the development of the world's inaugural 14 Tesla MRI scanner. The heightened sensitivity of this scanner will enable researchers to achieve more comprehensive brain imaging, leading to an improved understanding of brain function. Additionally, it will provide fresh insights into disease mechanisms and their treatment across the entire human body.
The installation of MRI machines is on the rise in emerging countries, marking a significant shift in healthcare infrastructure. The increase can be attributed to several factors, including rising healthcare budgets, a growing middle-class population, and the recognition of the vital role that advanced medical imaging plays in early diagnosis and treatment. Additionally, the growing awareness among healthcare professionals and the public about the benefits of MRI in detecting and monitoring various medical conditions has driven this expansion. The availability of MRI services is improving access to high-quality healthcare, allowing for more accurate diagnosis and better patient outcomes. This trend reflects a positive step towards bridging the healthcare gap between developed and emerging nations.
The global magnetic resonance imaging (MRI) market experienced significant impacts due to the COVID-19 pandemic. Initially, as healthcare resources were diverted towards managing the pandemic, non-essential medical procedures, including elective MRI scans, were postponed or canceled to prioritize COVID-19 patients. It led to a temporary downturn in MRI utilization and revenue for many healthcare facilities. However, the pandemic highlighted the importance of advanced diagnostic imaging in healthcare. As COVID-19 cases surged, MRI played a crucial role in assessing the extent of lung damage and monitoring patients' conditions. Moreover, the awareness of the need for faster and more efficient MRI diagnosis for COVID-19-related complications led to innovations in MRI technology. In the post-COVID-19 era, there has been a notable surge in the utilization of AI and machine learning in MRI, revolutionizing the field of medical imaging. These technologies are enhancing diagnostic accuracy, automating image analysis, and expediting the interpretation of MRI scans.
The global magnetic resonance imaging market features a landscape dominated by key players such as GE Healthcare Technologies Inc., Canon Medical System Corporation, Koninklijke Philips N.V, Siemens Healthineers AG, Hitachi Ltd, Aurora Imaging Technologies Inc., Fujifilm Holdings Corporation, and others. Companies are enhancing their imaging capabilities by manufacturing MRI scanners that have ultra-high field strength by surpassing the old high field strength of 3 Tesla. Market players are designing MRI scanners that are open or have wide bore for patients that are claustrophobic. Market players are developing partnerships to reach emerging markets.
In September 2023, Siemens Healthineers announced the FDA approval of Magnetom Viato.Mobile, a novel 1.5 Tesla (1.5T) magnetic resonance (MR) imaging scanner. This MRI scanner is specially designed for mobile applications, offering increased versatility for deploying MR imaging. It can be conveniently set up on a trailer, facilitating transportation to remote locations, thus extending the accessibility of advanced medical imaging to patients, including those with significant health issues, who would otherwise face long journeys for such services.
In October 2023, Philips announced its collaboration with Quibim to introduce advanced AI-driven imaging software aimed at prostate cancer detection. By combining Philips' innovative AI-enhanced MR imaging software with Quibim's AI-powered image analysis software, healthcare providers can expedite and simplify prostate cancer diagnosis and care.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work